GCP-2 Human

Granulocyte Chemotactic Protein 2 (CXCL6) Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Structure and Biochemical Properties

GCP-2 Human is a 72-amino-acid protein with a molecular weight of 7.9 kDa . Produced in E. coli for research purposes, it is non-glycosylated and exists as a single polypeptide chain . Its amino acid sequence includes a conserved NH₂-terminal domain and a COOH-terminal helix region critical for receptor binding and antimicrobial activity .

Antibacterial Activity Profile

Bacterial SpeciesMinimal Bactericidal Concentration (μM)Activity MechanismSource
S. aureus0.063 ± 0.01Membrane disruption
E. coli0.37 ± 0.03Surface binding and leakage
S. pneumoniae0.25 ± 0.02Lysis of cell walls

Isoform Heterogeneity

N-terminal truncation isoforms of GCP-2 have been identified, with varying biological potencies. For example, truncated forms of mouse GCP-2 exhibit enhanced chemotactic activity compared to the full-length human protein .

Clinical and Diagnostic Relevance

GCP-2 Human serves as a biomarker in inflammatory diseases and infections.

Acute Appendicitis (AA)

  • Diagnostic Utility: Elevated serum GCP-2 levels correlate with AA severity, particularly in complex cases (gangrenous/perforated) .

  • Correlation: Strong positive correlation with hs-CRP (r = 0.756) and moderate correlation with WBC count (r = 0.468) .

GCP-2 Levels in AA Patients

Patient GroupGCP-2/CXCL6 Level (pg/mL)Comparison to ControlsSource
Complex AA (abscess/perforation)45 ± 12↑ vs. non-complex AA
Non-complex AA28 ± 8↑ vs. healthy controls

Periodontitis

GCP-2 levels correlate with disease severity, acting as a functional adjunct to IL-8 in inflamed gingival tissues .

Research Applications and Methodologies

GCP-2 Human is widely used in experimental and diagnostic studies.

ELISA-Based Quantification

The Quantikine ELISA kit (R&D Systems) measures GCP-2 in serum, plasma, and cell culture supernatants. Recovery rates exceed 90% in most matrices .

Recovery Efficiency in Matrices

MatrixAverage Recovery (%)Range (%)Source
Cell Culture Media10493–114
EDTA Plasma9989–109
Serum9588–104

Purification and Stability

  • Storage: Lyophilized protein is stable at -18°C; reconstituted solutions require refrigeration (2–7°C) .

  • Purity: ≥98% as confirmed by RP-HPLC and SDS-PAGE .

Comparison with Related Chemokines

GCP-2 Human shares functional similarities with other ELR+ CXC chemokines but exhibits distinct properties.

Functional Comparison

ChemokineReceptorsKey FunctionsSource
IL-8 (CXCL8)CXCR1, CXCR2Neutrophil chemotaxis, angiogenesis
ENA-78 (CXCL5)CXCR2Modest antibacterial activity
GCP-2 (CXCL6)CXCR1, CXCR2High antibacterial activity, chemotaxis

Future Directions and Challenges

While GCP-2 Human is a promising therapeutic target, its translation into clinical applications requires further validation. Key areas include:

  1. Diagnostic Markers: Combining GCP-2 with imaging for appendicitis diagnosis .

  2. Antimicrobial Therapies: Exploiting its bactericidal properties against antibiotic-resistant pathogens .

  3. Neurological Disorders: Investigating its role in inflammation-driven diseases (e.g., Alzheimer’s) .

Product Specs

Introduction
Granulocyte Chemotactic Protein 2 (CXCL6), also called GCP-2, is a chemokine primarily known for its chemotactic effects on neutrophils, a type of white blood cell. GCP-2 exerts its actions by binding to and activating specific receptors on the surface of neutrophils, namely CXCR1 and CXCR2. This interaction triggers the directed movement of neutrophils towards the source of GCP-2. In addition to its chemotactic properties, GCP-2 exhibits potent antibacterial activity against both Gram-positive and Gram-negative bacteria, contributing to the body's defense mechanisms against infections. Furthermore, GCP-2 plays a role in angiogenesis, the formation of new blood vessels.
Description
Recombinant human GCP-2, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 72 amino acids. It has a molecular weight of 7.9 kDa.
Physical Appearance
White, sterile-filtered powder obtained by lyophilization (freeze-drying).
Formulation
GCP-2 protein was lyophilized from a 0.2 µm filtered solution concentrated in phosphate-buffered saline (PBS) at a pH of 7.4.
Solubility
To reconstitute the lyophilized GCP-2, it is recommended to dissolve it in sterile 18 MΩ·cm H2O at a concentration of at least 100 µg/ml. This solution can then be further diluted in other aqueous solutions as needed.
Stability
Lyophilized GCP-2 remains stable at room temperature for up to 3 weeks. However, for long-term storage, it is recommended to store it in a desiccated state below -18°C. After reconstitution, GCP-2 should be stored at 4°C for 2-7 days. For extended storage, it can be stored below -18°C, but the addition of a carrier protein (0.1% HSA or BSA) is advised. Avoid repeated freeze-thaw cycles to maintain protein integrity.
Purity
The purity of GCP-2 is greater than 98.0%, as determined by: (a) Reverse-phase high-performance liquid chromatography (RP-HPLC) analysis. (b) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Biological Activity
The recombinant GCP-2 exhibits full biological activity compared to the standard GCP-2. Its biological activity, as assessed by a chemotaxis bioassay using human neutrophils, falls within a concentration range of 10-50 ng/ml. This corresponds to a specific activity of 20,000-100,000 IU/mg.
Synonyms
C-X-C motif chemokine 6, Chemokine alpha 3, CKA-3, Granulocyte chemotactic protein 2, GCP-2, Small-inducible cytokine B6.
Source
Escherichia Coli.
Amino Acid Sequence
VLTELRCTCL RVTLRVNPKT IGKLQVFPAG PQCSKVEVVA SLKNGKQVCL DPEAPFLKKV IQKILDSGNK KN.

Q&A

What is human GCP-2/CXCL6 and what distinguishes it from other chemokines?

GCP-2/CXCL6 is a CXC chemokine that functions as a neutrophil chemoattractant utilizing both IL-8/CXCL8 receptors. While functionally similar to IL-8 in neutrophil attraction, GCP-2 is structurally most closely related to epithelial cell-derived neutrophil attractant-78 (ENA-78)/CXCL5 . The protein exists in multiple forms (approximately 6 kDa) due to N-terminal truncation heterogeneity, with four distinct forms identifiable through reverse phase HPLC .

In terms of biological activity, GCP-2 demonstrates particular characteristics that distinguish it from related chemokines:

FeatureGCP-2/CXCL6IL-8/CXCL8ENA-78/CXCL5
Receptor usageUses both IL-8 receptorsUses both IL-8 receptorsMore selective
Neutrophil gelatinase B release5-10× lower activityActive at 2 nMComparable to GCP-2
In vivo neutrophil recruitmentSignificant but less than IL-8Most potentComparable to GCP-2
Monocyte attractionNo activity observedSome activityLimited activity

GCP-2 consistently shows unique production patterns and regulation that differ from other CXC chemokines, suggesting specialized physiological roles .

Which cell types produce GCP-2 and under what experimental conditions?

GCP-2 production demonstrates notable cell-type specificity in experimental settings:

For experimental induction, researchers should note that while IL-8 responds similarly to various stimuli (TNF-α, measles virus, dsRNA), GCP-2 shows distinct stimulus specificity, with IL-1β being the predominant inducer in most cell types and LPS being relatively more effective for GCP-2 than IL-8 in fibroblasts .

How can researchers effectively isolate and identify GCP-2 from biological samples?

Isolation and identification of GCP-2 from biological samples requires a systematic approach:

  • Source selection: Based on current evidence, stimulated human osteosarcoma cells (MG-63) provide an effective source for GCP-2 isolation .

  • Purification protocol:

    • Initial extraction via standard protein isolation techniques

    • Amino acid sequence analysis for identification

    • Reverse phase HPLC for separation of truncated forms

  • Detection considerations: When measuring GCP-2, researchers should employ ELISA methods capable of recognizing all post-translationally modified GCP-2 isoforms to ensure comprehensive quantification .

  • Validation: In vivo confirmation through immunohistochemistry methods provides essential validation of in vitro findings .

Researchers should be aware that GCP-2 secretion consistently remains quantitatively inferior to IL-8 across experimental conditions, necessitating sufficiently sensitive detection methods .

How should researchers design functional assays to differentiate GCP-2 activity from related chemokines?

When designing functional assays to differentiate GCP-2 activity from related chemokines, researchers should implement a multi-parameter approach:

  • Granulocyte activation assays:

    • Neutrophil gelatinase B release assays reveal that GCP-2 exhibits 5-10 fold lower specific activity compared to IL-8 (which is active at 2 nM) .

    • Dose-response curves (1-100 nM) should be standard to capture these potency differences.

  • Migration assays:

    • Polycarbonate micropore membrane assays show GCP-2 and GRO alpha have comparable maximal chemotactic indices to IL-8, but with minimal effective doses of 3-10 nM (compared to IL-8's 10-fold higher potency) .

    • Include controls such as IP-10, which remains inactive in this assay at doses up to 100 nM .

  • In vivo chemotaxis assessment:

    • The rabbit skin model provides valuable in vivo verification, with intradermal injection of 200 ng/site GCP-2 provoking significant granulocyte infiltration (though less than IL-8 and GRO alpha) .

    • Parallel assessment of monocyte attraction (negative for GCP-2) provides additional specificity .

  • Receptor usage analysis:

    • Receptor blocking studies using specific antibodies against CXCR1 and CXCR2 can help differentiate chemokines based on receptor preference.

    • Calcium flux assays in receptor-transfected cell lines provide quantitative comparison of receptor activation dynamics.

This comprehensive approach allows researchers to fully characterize the functional profile of GCP-2 relative to other chemokines .

What methodological challenges exist in correlating GCP-2 expression with specific pathological conditions?

Several significant methodological challenges must be addressed when investigating correlations between GCP-2 expression and pathological conditions:

  • Heterogeneity of protein forms: GCP-2 exhibits multiple truncated forms at the amino terminus, each potentially possessing different bioactivities. Researchers must employ techniques capable of distinguishing these variants (e.g., reverse phase HPLC) and assessing their relative abundance in pathological samples .

  • Contextual expression patterns: GCP-2 production is tightly regulated in normal mesenchymal cells and follows distinct patterns compared to other chemokines like IL-8. This contextual expression necessitates careful selection of appropriate control samples and conditions .

  • Quantification limitations: GCP-2 secretion consistently remains inferior to IL-8 across experimental conditions, requiring highly sensitive detection methods to accurately quantify expression differences in disease states .

  • Cell-type specificity: Given that different cell types (mesenchymal vs. immune cells) show distinct GCP-2 production capabilities and responses to stimuli, studies must carefully account for tissue composition when interpreting expression patterns in pathological samples .

  • Stimulus interaction effects: Complex interaction effects between stimuli (e.g., IFN-γ down-regulation of GCP-2 induced by other factors) can significantly complicate interpretation of expression patterns in disease states where multiple inflammatory mediators are present .

Researchers should employ multi-parameter analysis approaches incorporating both protein and mRNA quantification across different cell types within the tissue microenvironment to address these challenges.

What is the Global Consciousness Project 2.0 and what methodologies does it employ?

The Global Consciousness Project 2.0 (GCP 2.0) is a research initiative investigating the relationship between individual and global consciousness, specifically examining how shared experiences and collective intentions may influence a proposed global consciousness field .

The core methodological approach employs:

  • Random Number Generator (RNG) networks: A distributed system of RNG devices hosted by citizen scientists worldwide that generate random data continuously .

  • Event correlation analysis: Statistical analysis of deviations from randomness in the RNG network during significant global events, such as large-scale emotional experiences or collective meditations .

  • Cluster deployment strategy: The current methodology calls for deployment of 1,000 new RNGs with:

    • 500 devices arranged in clusters of 20 RNGs in 25 major global cities

    • 500 devices distributed in smaller cities, towns, and rural locations

  • Heart coherence measurements: Integration of heart-focused meditation practices with RNG measurements to assess potential correlations between heart coherence states and global field effects .

This research design aims to address questions about how collective emotional experiences impact humanity and whether intentional practices can measurably influence what researchers propose as a global consciousness field .

How does GCP 2.0 research detect and analyze potential effects of human consciousness on random systems?

GCP 2.0 employs specific methodologies to detect and analyze potential effects of human consciousness on random systems:

  • Baseline establishment: Continuous data collection from globally distributed RNGs establishes expected random patterns under normal conditions .

  • Event analysis protocol:

    • Predetermined time windows around significant global events

    • Statistical analysis of deviations from expected randomness

    • Comparison of event-related data against baseline expectations

  • Example analysis case: During the Israel-Hamas conflict (beginning October 7th, 2023), researchers observed distinct shifts in the GCP 2.0 network corresponding to the escalation of hostilities. Analysis began at 06:00 local time and continued for 24 hours, revealing patterns that researchers interpret as evidence of impact on the global field .

  • Heart-coherence meditation experiments: In one documented study, researchers measured RNG behavior during an event where approximately 2,000 individuals engaged in heart-coherent states with intentions to affect global consciousness. Data showed that network coherence significantly increased coinciding with the meditation period .

  • Data visualization: Time-series graphing of network coherence patterns relative to event timelines provides visual representation of potential correlations .

This analytical framework attempts to identify statistically significant deviations from randomness that correlate with human events of global significance or intentional consciousness practices .

What considerations should researchers address when designing studies involving GCP 2.0 methodologies?

Researchers designing studies using GCP 2.0 methodologies should address several key considerations:

  • Statistical power requirements:

    • The current infrastructure goal of 1,000 RNGs reflects the scale needed for adequate statistical power

    • Cluster designs (20 RNGs per location) enable detection of localized effects

    • Research questions should be calibrated to the available network density

  • Event selection criteria:

    • Clear definition of what constitutes a "significant global event"

    • Pre-registration of events and analysis windows to prevent post-hoc selection bias

    • Categorization of events by type (tragic, celebratory, intentional, spontaneous)

  • Control conditions:

    • Implementation of appropriate control periods

    • Counter-balanced designs when studying intentional consciousness effects

    • Consideration of geographic and temporal controls

  • Methodological transparency:

    • Documentation of all analytical decisions and statistical approaches

    • Open data policies for independent verification

    • Clear reporting of both positive and negative results

  • Geographic and cultural considerations:

    • The distributed nature of RNG networks (with clusters in 25 major cities) requires accounting for cultural and geographical variables

    • Considerations for how regional events may influence global measurements

    • Strategies for distinguishing local from global effects

Researchers should also be mindful that studies investigating consciousness effects require particularly rigorous methodological controls to address potential skepticism in the broader scientific community.

What ethical and regulatory frameworks govern human participation in GCP-2 research?

Whether studying GCP-2/CXCL6 or participating in Global Consciousness Project 2.0 research, investigators must adhere to established human subjects protection frameworks:

  • Regulatory compliance:

    • Research must comply with HHS human subjects protections (45 CFR part 46)

    • If under an Investigational New Drug Application (IND) or Investigational Device Exemption (IDE), FDA regulations also apply (21 CFR 50)

    • International research must additionally comply with local regulations and ethical standards

  • Special protections:

    • Additional protections apply for vulnerable populations:

      • Pregnant women, human fetuses, and neonates

      • Prisoners

      • Children

  • Confidentiality requirements:

    • NIH-funded research automatically receives Certificate of Confidentiality (CoC) protection

    • CoCs prohibit disclosure of identifiable, sensitive research information except in specific circumstances:

      • When required by other Federal, State, or local laws

      • When the subject consents

      • For purposes of scientific research compliant with human subjects regulations

  • Informed consent requirements:

    • For GCP 2.0 participation: Subjects must understand the nature of consciousness research

    • For GCP-2/CXCL6 studies: Clinical protocols require detailed consent regarding biological samples

    • Subjects must be informed of protections and limitations provided by CoCs

All researchers, sub-awardees, and anyone receiving identifiable sensitive information are subject to these disclosure restrictions .

How should researchers implement Good Clinical Practices in studies involving GCP-2/CXCL6?

When conducting research involving GCP-2/CXCL6, particularly in clinical contexts, researchers should implement Good Clinical Practices through:

  • Protocol development:

    • Clear specification of GCP-2/CXCL6 isolation and analysis methods

    • Detailed procedures for sample collection, processing, and storage

    • Comprehensive inclusion/exclusion criteria for human subjects

    • Standardized operating procedures for all laboratory analyses

  • Investigator responsibilities:

    • Qualification and training documentation for all personnel

    • Proper delegation of research tasks

    • Maintenance of accurate source documentation

    • Timely reporting of adverse events

  • IRB oversight:

    • Initial and continuing review of research protocols

    • Assessment of risk-benefit ratios for human subjects

    • Evaluation of informed consent procedures

    • Monitoring of study progress and protocol adherence

  • Quality control measures:

    • Regular monitoring of data integrity

    • Calibration and maintenance of laboratory equipment

    • Independent verification of critical measurements

    • Documentation of any protocol deviations

  • Data management:

    • Systems for secure data storage

    • Procedures for data validation

    • Methods for detecting and correcting errors

    • Plans for data sharing and publication

These practices ensure that GCP-2/CXCL6 research maintains high scientific standards while protecting human subjects' rights and welfare in accordance with both international guidelines and local regulations .

What methodological approaches can address the unique ethical considerations in Global Consciousness Project 2.0 citizen science?

The Global Consciousness Project 2.0's citizen science component presents unique ethical considerations requiring specific methodological approaches:

  • Participant recruitment and training:

    • Clear documentation of RNG host responsibilities

    • Training materials that explain scientific purpose without biasing expectations

    • Informed consent process addressing both benefits and limitations of participation

    • Transparent communication about data usage and research findings

  • Data governance structure:

    • Protocols for handling potentially sensitive global event data

    • Clear policies regarding participant withdrawal and data retention

    • Systems for maintaining participant privacy while enabling research collaboration

    • Mechanisms for citizen scientists to provide input on research priorities

  • Community engagement framework:

    • Structured opportunities for participant feedback

    • Regular communication about research progress

    • Development of community guidelines for meditation events

    • Balanced presentation of preliminary findings to avoid confirmation bias

  • Cross-cultural considerations:

    • Methods for addressing diverse cultural interpretations of consciousness

    • Protocols for respectfully acknowledging local belief systems

    • Recognition of different attitudes toward technology and privacy across global locations

    • Strategies for inclusive participation across socioeconomic barriers

  • Ethical management of expectations:

    • Clear distinction between research hypotheses and established findings

    • Balanced communication about the preliminary nature of consciousness field research

    • Methods to prevent therapeutic misconception among meditation participants

    • Procedures for responsibly communicating results without sensationalism

These methodological approaches help ensure that GCP 2.0 research maintains scientific integrity while respecting participants' autonomy and cultural contexts across its global research network .

What methodological approaches can integrate findings from both GCP-2/CXCL6 and consciousness research?

While representing distinct research domains, both GCP-2/CXCL6 and consciousness research share methodological considerations that offer potential integrative approaches:

  • Psychoneuroimmunology framework:

    • GCP-2/CXCL6 research demonstrates specific immunomodulatory functions influenced by various stimuli

    • Consciousness research examines potential correlations between mental states and physical systems

    • Integration through study designs examining whether meditation states influence inflammatory marker expression, including chemokines like GCP-2

  • Bioinformatics and network analysis:

    • Application of pattern recognition algorithms across both domains

    • Network analysis methodologies applicable to both biological signaling networks and distributed RNG systems

    • Development of computational models incorporating both physiological and consciousness variables

  • Methodological cross-pollination:

    • Adaptation of rigorous biological experimental controls to consciousness research

    • Application of field-effect analysis techniques from physics to biological systems

    • Development of standardized protocols for measuring both biological and consciousness variables in integrated studies

  • Translational research approaches:

    • Investigation of how stress states (measured via GCP 2.0 methodologies) might correlate with inflammatory marker expression

    • Examination of whether heart-coherent states influence neutrophil chemotaxis and other GCP-2 mediated processes

    • Development of biomarker panels that might correlate with consciousness states

These integrative approaches could potentially bridge traditionally separate research domains while maintaining rigorous scientific standards .

What methodological challenges must be addressed in future GCP-2 human research?

Future research in both GCP-2/CXCL6 and Global Consciousness Project 2.0 domains faces several methodological challenges requiring innovative approaches:

  • GCP-2/CXCL6 research challenges:

    • Development of in vivo imaging techniques for tracking chemokine activity in real-time

    • Creation of more sensitive assays capable of detecting the lower expression levels of GCP-2 compared to IL-8

    • Design of studies that can differentiate biological effects of the multiple truncated forms of GCP-2

    • Methods for monitoring temporal regulation patterns in complex inflammatory environments

  • Global Consciousness Project 2.0 challenges:

    • Development of more robust statistical approaches for analyzing global field effects

    • Creation of control methodologies addressing potential criticisms regarding data selection

    • Integration of additional measurement technologies beyond RNGs

    • Design of experiments capable of distinguishing causation from correlation in consciousness field studies

  • Shared methodological challenges:

    • Establishing reproducible protocols across diverse research settings

    • Developing interdisciplinary training programs to bridge specialized knowledge domains

    • Creating standardized reporting guidelines appropriate to each field

    • Addressing funding limitations for innovative cross-disciplinary approaches

  • Data integration challenges:

    • Development of common ontologies across disparate research domains

    • Creation of data repositories capable of handling diverse data types

    • Establishment of metadata standards enabling cross-study analysis

    • Implementation of data sharing protocols that respect both scientific openness and subject confidentiality

Addressing these challenges will require collaborative efforts across disciplines and innovative methodological approaches tailored to the unique aspects of each research domain.

What are the most promising directions for advancing GCP-2 human research methodologies?

Several promising directions exist for advancing methodologies in both GCP-2/CXCL6 and Global Consciousness Project 2.0 research:

  • Advanced GCP-2/CXCL6 methodologies:

    • Single-cell analysis techniques to elucidate cell-specific GCP-2 production and response patterns

    • CRISPR-based approaches for precise manipulation of GCP-2 expression and receptor function

    • Development of specific GCP-2 antagonists and agonists to probe function in complex systems

    • Computational modeling of chemokine network dynamics incorporating differential regulation patterns

  • Enhanced Global Consciousness Project 2.0 approaches:

    • Integration of machine learning algorithms for pattern detection in RNG data

    • Development of more sophisticated RNG hardware with enhanced sensitivity

    • Implementation of quantum-based random systems as next-generation measurement tools

    • Creation of real-time visualization interfaces for global field measurements

  • Collaborative research infrastructures:

    • Establishment of interdisciplinary research centers focusing on mind-body interactions

    • Development of standardized protocols enabling multi-site replication studies

    • Creation of global databases for both biological and consciousness research findings

    • Formation of research networks connecting diverse expertise across traditional boundaries

  • Translational applications:

    • Exploration of GCP-2 targeted therapies for specific inflammatory conditions based on its unique regulation patterns

    • Investigation of potential applications of consciousness field research to stress reduction and community resilience

    • Development of biomarker panels incorporating both physiological and psychological parameters

    • Creation of integrated intervention approaches addressing both biological and consciousness dimensions of human health

Product Science Overview

Introduction

Granulocyte Chemotactic Protein 2 (GCP-2), also known as C-X-C Motif Chemokine Ligand 6 (CXCL6), is a small cytokine belonging to the CXC chemokine family. This protein plays a crucial role in the immune system by acting as a chemoattractant for neutrophilic granulocytes. It is involved in various biological processes, including chemotaxis, angiogenesis, and antibacterial activity.

Gene and Protein Structure

The gene encoding CXCL6 is located on human chromosome 4q13.3, within a cluster of other CXC chemokine genes . The protein itself is characterized by the presence of a CXC motif, which is a conserved sequence of amino acids that is critical for its function. The human recombinant form of CXCL6 is produced using recombinant DNA technology, allowing for the production of large quantities of the protein for research and therapeutic purposes.

Biological Functions

CXCL6 is primarily known for its role in chemotaxis, the process by which cells move towards chemical signals. It specifically attracts neutrophil granulocytes, a type of white blood cell that plays a key role in the body’s defense against infections . The chemotactic effect of CXCL6 is mediated through its interaction with chemokine receptors CXCR1 and CXCR2 .

In addition to its chemotactic properties, CXCL6 has strong antibacterial activity against both Gram-positive and Gram-negative bacteria . This antibacterial action is significantly higher compared to other related chemokines such as CXCL5 and CXCL7 . Furthermore, CXCL6 exhibits angiogenic properties, promoting the formation of new blood vessels, which is essential for wound healing and tissue repair .

Clinical Significance

The ability of CXCL6 to attract neutrophils and its potent antibacterial activity make it a critical component of the immune response. It has been implicated in various inflammatory conditions and infections. For instance, elevated levels of CXCL6 have been observed in conditions such as tonsillitis and certain types of adenomas . Its role in angiogenesis also suggests potential applications in promoting wound healing and tissue regeneration.

Research and Therapeutic Applications

Human recombinant CXCL6 is widely used in research to study its functions and potential therapeutic applications. By using recombinant DNA technology, researchers can produce large quantities of CXCL6, enabling detailed studies on its role in immune responses, inflammation, and tissue repair. Additionally, recombinant CXCL6 can be used in therapeutic applications to enhance immune responses or promote healing in various clinical settings.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.